Non-Medical Prescription Drug Use Among High-Risk Youth

高危青少年的非医疗处方药使用情况

基本信息

  • 批准号:
    7319528
  • 负责人:
  • 金额:
    $ 48.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-28 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Substantial evidence suggests that the diversion of prescription drugs for non-medical use accounts for a rapidly increasing share of substances of abuse, particularly among high-risk youth and young adult populations. Yet, there is a scarcity of information about the use of these drugs, including what the substances are, how they are administered, and why they are initiated. Much of the available data on non-medical prescription drugs, which includes opioids, CMS depressants, and stimulants, is limited to survey data and older populations of users. Descriptive data is lacking about the non-medical use of prescription drugs among high-risk youth populations. We are proposing a two-city (New York and Los Angeles) comparative study of high-risk youth aged 16 to 25 who may be homeless, participating in the street economy, polydrug users and/or injection drug users. The project aims are to: describe why high-risk youth initiate non-medical prescription drug use; describe variability in the forms of prescription drugs available and behavioral practices employed in their administration; chart the social trajectory of the transition from prescription drug use into other types of controlled substances; and assess the consequences of chronic use of prescription drugs on increased risk for onset of behaviors associated with exposure to HIV and STIs. The project aims will be addressed during three study phases. Phase One will consist of a six month Community Assessment Process (CAP) to gather existing "local knowledge" about non-medical prescription drug use in each city. Phase Two will comprise a nine month qualitative study of 150 prescription drug users in New York and Los Angeles. Phase Three will constitute a 15 month cross-sectional, quantitative survey of 600 prescription drug users in New York and Los Angeles. Study findings will inform the development of a curriculum for community-based organizations aimed at reducing non-medical prescription drug use among high-risk youth. Public health research on non-medical prescription drug use is extremely limited, and little is currently known about how high-risk youth maintain healthy living standards in the face of their risky behavior. Results from the proposed study will fill a critical gap in the epidemiological literature on non-medical prescription drug use among high-risk youth who are at risk for negative health outcomes, including drug dependence, drug overdose, violence, victimization, and exposure to bloodborne pathogens.
描述(由申请方提供):大量证据表明,处方药被转用于非医疗用途是滥用药物比例迅速增加的原因,特别是在高危青年和年轻成人人群中。然而,关于这些药物的使用的信息很少,包括这些物质是什么,如何管理,以及为什么开始使用。关于非医疗处方药的大部分可用数据,包括阿片类药物,CMS抑制剂和兴奋剂,仅限于调查数据和老年用户群体。缺乏关于高危青年人群非医疗使用处方药的描述性数据。我们建议在两个城市(纽约和洛杉矶)对16至25岁的高危青年进行比较研究,这些青年可能无家可归,参与街头经济,使用多种毒品和/或注射毒品。该项目的目标是:描述高危青年开始使用非医疗处方药的原因;描述现有处方药形式的变异性及其管理中采用的行为做法;绘制从使用处方药过渡到其他类型受管制物质的社会轨迹;评估长期使用处方药对增加与接触艾滋病毒和性传播感染相关的行为发生风险的后果。该项目的目标将在三个研究阶段进行。第一阶段将包括一个为期六个月的社区评估过程(CAP),以收集每个城市现有的关于非医疗处方药使用的“当地知识”。第二阶段将包括对纽约和洛杉矶的150名处方药使用者进行为期9个月的定性研究。第三阶段将对纽约和洛杉矶的600名处方药使用者进行为期15个月的横向定量调查。研究结果将有助于为社区组织制定课程,以减少高危青年使用非医疗处方药的情况。关于非医疗处方药使用的公共卫生研究非常有限,目前对高危青年如何在面临危险行为时保持健康的生活水平知之甚少。拟议研究的结果将填补流行病学文献中关于高危青年使用非医疗处方药的关键空白,这些青年面临负面健康结果的风险,包括药物依赖,药物过量,暴力,受害和暴露于血源性病原体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen E Lankenau其他文献

S144 - “If You Go in With a Plan and a Goal, It Can Be Therapeutic”: A Qualitative Exploration of Psychedelic Use Among Emerging Adult Cannabis Users in Los Angeles
S144 - “如果你带着计划和目标去使用,它可能具有治疗作用”:对洛杉矶新兴成年大麻使用者中迷幻剂使用的定性探索
  • DOI:
    10.1016/j.drugalcdep.2024.111564
  • 发表时间:
    2025-02-01
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Bridgid Conn;Meagan Suen;Kaia L. Sheean;Janna Ataiants;Ekaterina Fedorova;Stephen E Lankenau;Carolyn F. Wong
  • 通讯作者:
    Carolyn F. Wong

Stephen E Lankenau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen E Lankenau', 18)}}的其他基金

UnityPhilly Response App for Overdose Reversal: Assessing Citywide Effectiveness and Sustainability
UnityPhilly 逆转用药过量响应应用程序:评估全市范围的有效性和可持续性
  • 批准号:
    10585638
  • 财政年份:
    2023
  • 资助金额:
    $ 48.98万
  • 项目类别:
Piloting a naloxone intervention in an emergency response community to reduce opioid overdoses in Philadelphia
在费城的应急响应社区试点纳洛酮干预措施,以减少阿片类药物过量
  • 批准号:
    9403417
  • 财政年份:
    2017
  • 资助金额:
    $ 48.98万
  • 项目类别:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
医用大麻,新兴成人
  • 批准号:
    8685230
  • 财政年份:
    2013
  • 资助金额:
    $ 48.98万
  • 项目类别:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
医用大麻,新兴成人
  • 批准号:
    9228355
  • 财政年份:
    2013
  • 资助金额:
    $ 48.98万
  • 项目类别:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
医用大麻,新兴成人
  • 批准号:
    8813547
  • 财政年份:
    2013
  • 资助金额:
    $ 48.98万
  • 项目类别:
Medical Marijuana, Emerging Adults, and Community: Connecting Health and Policy
医用大麻、新兴成年人和社区:连接健康和政策
  • 批准号:
    10207574
  • 财政年份:
    2013
  • 资助金额:
    $ 48.98万
  • 项目类别:
Medical Marijuana, Emerging Adults, and Community: Connecting Health and Policy
医用大麻、新兴成年人和社区:连接健康和政策
  • 批准号:
    10439715
  • 财政年份:
    2013
  • 资助金额:
    $ 48.98万
  • 项目类别:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
医用大麻,新兴成人
  • 批准号:
    8503943
  • 财政年份:
    2013
  • 资助金额:
    $ 48.98万
  • 项目类别:
Medical Marijuana, Emerging Adults & Community: Connecting Health and Policy
医用大麻,新兴成人
  • 批准号:
    8816603
  • 财政年份:
    2013
  • 资助金额:
    $ 48.98万
  • 项目类别:
Medical Marijuana, Emerging Adults, and Community: Connecting Health and Policy
医用大麻、新兴成年人和社区:连接健康和政策
  • 批准号:
    9793996
  • 财政年份:
    2013
  • 资助金额:
    $ 48.98万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了